Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Glaukos Corp (GKOS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,511,173
  • Shares Outstanding, K 36,158
  • Annual Sales, $ 181,280 K
  • Annual Income, $ -12,950 K
  • 60-Month Beta 1.63
  • Price/Sales 13.78
  • Price/Cash Flow N/A
  • Price/Book 13.87

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.12
  • Number of Estimates 6
  • High Estimate -0.07
  • Low Estimate -0.18
  • Prior Year -0.08
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
67.41 +3.03%
on 04/18/19
83.14 -16.47%
on 03/26/19
-3.63 (-4.97%)
since 03/18/19
3-Month
59.14 +17.43%
on 01/29/19
83.14 -16.47%
on 03/26/19
+6.77 (+10.80%)
since 01/18/19
52-Week
29.09 +138.74%
on 04/19/18
83.14 -16.47%
on 03/26/19
+39.75 (+133.84%)
since 04/18/18

Most Recent Stories

More News
Glaukos Corporation to Release First Quarter 2019 Financial Results after Market Close on May 8

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical...

GKOS : 69.45 (+0.51%)
Prospective, Randomized Trial Highlights 5-Year Performance of 2 Standalone Glaukos iStents(R) vs. Topical Prostaglandin in Newly Diagnosed Glaucoma Patients

Glaukos Corporation (NYSE:GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical...

GKOS : 69.45 (+0.51%)
Glaukos (GKOS) Banks on Solid Pipeline Amid Stiff Competition

Glaukos' (GKOS) strong pipeline is indicative of brighter prospects ahead. However, cutthroat competition in the medical-device industry is worrisome.

TCMD : 48.28 (-3.71%)
PEN : 128.97 (+1.69%)
GKOS : 69.45 (+0.51%)
FLDM : 12.83 (-1.69%)
New Research: Key Drivers of Growth for Fresh Del Monte Produce, Baker Hughes, a GE company, HollyFrontier, Glaukos, HCI Group, and Revance Therapeutics -- Factors of Influence, Major Initiatives and Sustained Production

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Fresh Del Monte Produce, Inc....

FDP : 26.80 (+0.37%)
HFC : 47.34 (-2.23%)
GKOS : 69.45 (+0.51%)
BHGE : 25.60 (-0.70%)
HCI : 42.14 (+1.06%)
RVNC : 13.49 (+1.97%)
Cardiovascular S is Among the Companies in the Health Care Equipment Industry with the Best Relative Performance (CSII , GKOS , IVC , BAX , HOLX )

Here are the top 5 stocks in the Health Care Equipment industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

IVC : 6.68 (-3.05%)
GKOS : 69.45 (+0.51%)
CSII : 34.16 (+0.68%)
Shares of GKOS Up 29.5% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Glaukos Corp (NYSE:GKOS) on January 16th, 2019 at $61.71. In approximately 2 months, Glaukos Corp has returned 29.53% as of today's recent price of $79.93.

GKOS : 69.45 (+0.51%)
Shares of Nevro Corp Rank the Highest in Terms of Relative Performance in the Health Care Equipment Industry (NVRO , VAR , GKOS , RMD , NUVA )

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

NVRO : 65.58 (-0.17%)
VAR : 130.78 (-0.67%)
GKOS : 69.45 (+0.51%)
Glaukos Corp is Among the Companies in the Health Care Equipment Industry with the Best Relative Performance (GKOS , IDXX , HRC , TNDM, MASI )

Below are the top five companies in the Health Care Equipment industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that...

TNDM : 54.41 (-1.63%)
HRC : 95.62 (+0.29%)
GKOS : 69.45 (+0.51%)
IDXX : 218.49 (+1.37%)
Uptrend Call Working As Glaukos Corp Stock Rises 24.3% (GKOS)

SmarTrend identified an Uptrend for Glaukos Corp (NYSE:GKOS) on January 16th, 2019 at $61.71. In approximately 2 months, Glaukos Corp has returned 24.26% as of today's recent price of $76.68.

GKOS : 69.45 (+0.51%)
Glaukos Corp has the Best Relative Performance in the Health Care Equipment Industry (GKOS , IART , DHR , ABT , PODD )

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

IART : 51.14 (+1.98%)
GKOS : 69.45 (+0.51%)
DHR : 126.77 (+1.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade GKOS with:

Business Summary

Glaukos Corporation is an ophthalmic medical technology company. The Company develops, manufactures and markets medical devices for the treatment of glaucoma. Its product pipeline consists of iStent Inject, the iStent Supra and iDose. The company operates primarily in United States, Germany, Europe,...

See More

Key Turning Points

2nd Resistance Point 71.20
1st Resistance Point 70.33
Last Price 69.45
1st Support Level 67.99
2nd Support Level 66.53

See More

52-Week High 83.14
Last Price 69.45
Fibonacci 61.8% 62.49
Fibonacci 50% 56.11
Fibonacci 38.2% 49.74
52-Week Low 29.09

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar